Economist
0
What is microRNA and why did its discovery merit this year’s Nobel Prize for Medicine? – Healthcare Economist
0

This year the Nobel Prize in Medicine went to Victor Ambros, currently Professor of Natural Sciences at the University of ...

0
The new OMB Social Welfare Function – Healthcare Economist
0

Recently, the Office of Management and Budget has published new procedures for evaluating government regulation (Circular A-4) and economic policies ...

0
Why aren’t people using Paxlovid? – Healthcare Economist
0

Paxlovid (nirmatrelvir-ritonavir) is effective in preventing hospitalization and death from COVID-19, but few people use ...

0
What share of physicians are integrated within hospital systems? – Healthcare Economist
0

These questions may be more difficult to answer than they seem. While some doctors are completely independent and others ...

0
What are the new CMS Star Ratings Measures for 2025? – Healthcare Economist
0

My FTI colleagues Mark Van Ert and Krunal Patel summarize some of the new quality measures that will be incorporated into ...

0
Healthcare spending for individuals with FSAs and HSAs – Healthcare Economist
0

In the United States, health insurance premiums are tax-deductible (if paid through out-of-pocket expenses), but ...

0
Reporting Checklist for Discrete Choice Experiments in Health – Healthcare Economist
0

What are the key elements to report on your objective, attributes, experimental design, survey design, data collection ...

0
Some hopeful trends on opioid overdoses (finally) – Healthcare Economist
0

While opioid overdoses have been on the rise for decades, recent trends offer a ray of hope. NPR Reports: For the ...

0
Why is the market design for innovative pharmaceuticals not well understood? – Healthcare Economist
0

That is the title of a fantastic editorial by Olivença and others (2024)Many people, when they look at drug prices, think they are "too high" or "too low." ...

0
Does PBM Market Share Vary by Payer Type? – Healthcare Economist
0

An article by Qato and others (2024) quantifies the degree of concentration in the pharmacy benefit manager (PBM) market. ...

Tools4BLS
Logo
Register New Account
Compare items
  • Total (0)
Compare
0
Shopping cart